NDE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.287200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.787000E-01
Normal-vs-Stage2
3.394200E-01
Normal-vs-Stage3
9.945600E-01
Normal-vs-Stage4
2.049200E-01
Stage1-vs-Stage2
1.249380E-01
Stage1-vs-Stage3
8.557000E-01
Stage1-vs-Stage4
3.348000E-02
Stage2-vs-Stage3
2.657000E-01
Stage2-vs-Stage4
5.005800E-01
Stage3-vs-Stage4
1.118200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.439400E-01
Normal-vs-AfricanAmerican
4.774600E-01
Normal-vs-Asian
5.582000E-01
Caucasian-vs-AfricanAmerican
8.448000E-01
Caucasian-vs-Asian
8.163600E-01
AfricanAmerican-vs-Asian
9.847400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.572000E-01
Normal-vs-Female
5.292600E-01
Male-vs-Female
4.524000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.468200E-01
Normal-vs-Age(41-60Yrs)
2.927000E-01
Normal-vs-Age(61-80Yrs)
5.151200E-01
Normal-vs-Age(81-100Yrs)
6.420000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.611200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.697000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.866000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.692130E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.713650E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.925800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.609600E-01
Normal-vs-Daily Drinker
4.532600E-01
Normal-vs-Weekly Drinker
4.986600E-01
Normal-vs-Occasional Drinker
3.508200E-01
Normal-vs-Social Drinker
4.233600E-01
Non Drinker-vs-Daily Drinker
5.219200E-01
Non Drinker-vs-Weekly Drinker
9.037800E-01
Non Drinker-vs-Occasional Drinker
3.551600E-01
Non Drinker-vs-Social Drinker
3.141200E-01
Daily Drinker-vs-Weekly Drinker
6.683600E-01
Daily Drinker-vs-Occasional Drinker
8.032600E-01
Daily Drinker-vs-Social Drinker
5.378200E-01
Weekly Drinker-vs-Occasional Drinker
4.866400E-01
Weekly Drinker-vs-Social Drinker
3.707200E-01
Occasional Drinker-vs-Social Drinker
6.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.558200E-01
Normal-vs-Grade 2
2.870100E-02
Normal-vs-Grade 3
7.000200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.240000E-04
Grade 1-vs-Grade 3
1.846940E-04
Grade 1-vs-Grade 4
2.558200E-01
Grade 2-vs-Grade 3
2.533200E-01
Grade 2-vs-Grade 4
2.870100E-02
Grade 3-vs-Grade 4
7.000200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.600800E-01
Normal-vs-NonDiabetic
4.641000E-01
Diabetic-vs-NonDiabetic
9.038200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.798590E-01
Normal-vs-NoPancreatitis
4.789200E-01
Pancreatitis-vs-NoPancreatitis
5.066000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.533600E-01
Normal-vs-N1
3.598400E-01
N0-vs-N1
4.737800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.523360E-01
Normal-vs-TP53-NonMutant
7.079200E-01
TP53-Mutant-vs-TP53-NonMutant
2.22849999998997E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
